Immunome (IMNM) has released an update to notify the public and investors about the unregistered sales of equity securities.
Shares will be issued to Ayala at the Closing, utilizing an exemption from registration requirements under Section 4(a)(2) of the Securities Act, which applies to private transactions by an issuer. As a result, these shares won’t be publicly registered and can’t be sold in the U.S. without proper registration or a relevant exemption.
For further insights into IMNM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
